Public-registry site landscape for NCT07723963, a Juvenile Myoclonic Epilepsy study sponsored by Jazz Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07723963 (registry record) |
| Sponsor | Jazz Pharmaceuticals |
| Condition(s) | Juvenile Myoclonic Epilepsy |
| Phase | PHASE2 / PHASE3 |
| Listed sites | 10 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT07723963 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →